Meiji Holdings Co., Ltd.
Stock Price Chart
2026/01/15 UpdatedPrice Trend
2026/01/15 UpdatedPrice & Trading Details
2026/01/15 UpdatedPRICE
TRADING
Analyst Recommendations 7 analysts
Updated 2026/01/11Shareholder Composition
Updated 2026/01/11Top Mutual Funds / ETFs
Updated 2026/01/11Major Holders
Updated 2026/01/11| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
3.6M | +0.18% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
2.3M | +2.26% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
1.7M | +1.25% | |
|
J.P. Morgan Exchange-Traded Fund Trust-JPMorgan BetaBuilders Japan ETF
|
762.3K | +0.79% | |
|
DFA INVESTMENT TRUST CO-THE DFA INTERNATIONAL VALUE SERIES
|
589.1K | +18.01% | |
|
Dimensional ETF Trust-Dimensional International Value ETF
|
581.3K | +12.90% |
| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Pacer Advisors, Inc.
|
2.4K | -4.59% |
Dividend History 4Years Growth
Updated 2026/01/11| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥103 | +5.1% |
| 2024 | ¥98 | +2.6% |
| 2023 | ¥95 | +8.6% |
| 2022 | ¥88 | +12.9% |
| 2021 | ¥78 | - |
Financial Performance
2026/01/11 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥1,013,092M | ¥1,062,157M | ¥1,105,494M | ¥1,154,074M |
| Gross Profit | ¥323,249M | ¥306,802M | ¥327,345M | ¥339,100M |
| Operating Income | ¥92,922M | ¥75,434M | ¥84,322M | ¥84,702M |
| Pretax Income | ¥128,955M | ¥95,872M | ¥87,874M | ¥82,864M |
| Net Income | ¥87,497M | ¥69,424M | ¥50,675M | ¥50,800M |
| EPS | ¥303.62 | ¥247.39 | ¥181.56 | ¥186.08 |
| Operating Margin | 9.17% | 7.10% | 7.63% | 7.34% |
| Balance Sheet | ||||
| Total Assets | ¥1,117,459M | ¥1,136,217M | ¥1,205,288M | ¥1,184,472M |
| Total Equity | ¥673,335M | ¥711,915M | ¥746,529M | ¥748,288M |
| Total Liabilities | ¥444,124M | ¥424,302M | ¥458,759M | ¥436,184M |
| Cash | ¥67,409M | ¥63,519M | ¥106,858M | ¥78,191M |
| Interest-bearing Debt | ¥81,266M | ¥64,370M | ¥49,926M | ¥47,799M |
| Equity Ratio | 60.26% | 62.66% | 61.94% | 63.17% |
| D/E Ratio | 0.12 | 0.09 | 0.07 | 0.06 |
| Cash Flow | ||||
| Operating CF | ¥127,526M | ¥85,013M | ¥107,983M | ¥68,979M |
| Investing CF | -¥27,614M | -¥36,788M | -¥24,604M | -¥40,636M |
| Financing CF | -¥76,997M | -¥54,734M | -¥43,772M | -¥61,671M |
| Free CF | ¥34,361M | ¥12,843M | ¥54,539M | ¥12,356M |
| Efficiency | ||||
| ROE | 12.99% | 9.75% | 6.79% | 6.79% |
| ROA | 7.83% | 6.11% | 4.20% | 4.29% |
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥3,493
Rating Score: - (Based on 7 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Meiji Holdings Co., Ltd., through its subsidiaries, engages in the manufacture and sale of dairy products, confectionery food products and pharmaceuticals in Japan and internationally. The company operates through two segments, Food and Pharmaceuticals. The Food segment provides yogurt, milk, beverages, cheese, butter, margarine, cream, ice cream, prepared food, chocolate, gummy candy, sports nutrition, infant milk, liquid food, beauty products, feed, sugar, and corn sweeteners. The Pharmaceutical segment offers drugs for infectious and central nervous system disorders, vaccines, blood plasma products, generic drugs, and animal health products. Meiji Holdings Co., Ltd. was founded in 1916 and is headquartered in Tokyo, Japan.